Patents by Inventor Anna GOPIN

Anna GOPIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Depot systems comprising Cariprazine or salts thereof
    Patent number: 11931357
    Abstract: The present invention provides long-acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of Cariprazine or salts thereof, in a depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot compositions are preferably in the form of in-situ implants suitable for subcutaneous or intramuscular administration and provide prolonged release of the Cariprazine active ingredient and/or its metabolites desmethyl Cariprazine (DCAR) and didesmethyl Cariprazine (DDCAR) for a period of at least 4 weeks following a single administration. The present invention further provides methods of use of the depot compositions for the treatment of schizophrenia, major depressive disorder, and bipolar disorder.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: March 19, 2024
    Assignee: MAPI PHARMA LTD.
    Inventors: Shai Rubnov, Ehud Marom, Anna Gopin
  • DEPOT SYSTEMS COMPRISING CARIPRAZINE OR SALTS THEREOF
    Publication number: 20230293515
    Abstract: The present invention provides long-acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of Cariprazine or salts thereof, in a depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot compositions are preferably in the form of in-situ implants suitable for subcutaneous or intramuscular administration and provide prolonged release of the Cariprazine active ingredient and/or its metabolites desmethyl Cariprazine (DCAR) and didesmethyl Cariprazine (DDCAR) for a period of at least 4 weeks following a single administration. The present invention further provides methods of use of the depot compositions for the treatment of schizophrenia, major depressive disorder, and bipolar disorder.
    Type: Application
    Filed: February 14, 2023
    Publication date: September 21, 2023
    Applicant: Mapi Pharma Ltd.
    Inventors: Shai RUBNOV, Ehud MAROM, Anna GOPIN
  • Intermediate compounds and process for the preparation of efinaconazole
    Patent number: 9617241
    Abstract: The present invention relates to a process for the preparation of (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Efinaconazole) and intermediates used in such process.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: April 11, 2017
    Assignee: MAPI PHARMA LTD.
    Inventors: Anna Gopin, Shai Rubnov, Galina Zats, Ehud Marom
  • INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF EFINACONAZOLE
    Publication number: 20160355500
    Abstract: The present invention relates to a process for the preparation of (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Efinaconazole) and intermediates used in such process.
    Type: Application
    Filed: March 2, 2015
    Publication date: December 8, 2016
    Applicant: MAPI PHARMA LTD.
    Inventors: Anna GOPIN, Shai RUBNOV, Galina ZATS, Ehud MAROM